Skip to main content
MRKR logo

MRKR · Marker Therapeutics, Inc. · Share Buybacks

Track MRKR — free
$1.09 -0.23 (-17.42%) At close · Nov 20 Q1 2021 earnings call transcript
Market Cap
$18.17M
Shares
16.67M
Volume · Nov 20 1.97M Avg daily vol (3M) 703.97K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2024-11 $11,431,713 — —

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2018-12-31 $71,710
2017-12-31 $310,493
2016-12-31 $0
Key facts CIK 1094038 CUSIP 57055L206 13F (30d) 51 filings 34 filers Visit website Investor relations